Back to News
Market Impact: 0.6

New Strong Sell Stocks for October 1st

AGLPLAYCCRN
Company FundamentalsCorporate EarningsAnalyst EstimatesAnalyst Insights
New Strong Sell Stocks for October 1st

Agilon Health (AGL), Dave & Buster's Entertainment (PLAY), and Cross Country Healthcare (CCRN) have been added to the Zacks Rank #5 (Strong Sell) list, reflecting significant negative shifts in their earnings outlooks. This downgrade follows substantial downward revisions in current year earnings estimates over the past 60 days, with AGL's estimates falling by 96.8%, PLAY's by 71.8%, and CCRN's by 46.9%, signaling potential underperformance for these equities.

Analysis

Agilon Health (AGL), Dave & Buster's Entertainment (PLAY), and Cross Country Healthcare (CCRN) have been downgraded to a Zacks Rank #5 (Strong Sell), indicating a significant deterioration in their near-term outlook based on analyst sentiment. This action is underpinned by substantial negative revisions to their current-year consensus earnings estimates over the past 60 days. The most severe revision was for Agilon Health, whose estimate was cut by 96.8%, followed by Dave & Buster's with a 71.8% downward revision, and Cross Country Healthcare with a 46.9% reduction. These are not marginal adjustments but rather drastic cuts that signal a fundamental reassessment of the companies' profitability and operational performance, suggesting a high risk of stock underperformance in the near term.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment

Overall Sentiment

strongly negative

Sentiment Score

-0.80

Ticker Sentiment

AGL-0.90
CCRN-0.85
PLAY-0.90

Key Decisions for Investors

  • Investors with existing long positions in AGL, PLAY, or CCRN should re-evaluate their thesis, as the 'Strong Sell' rating combined with severe downward earnings revisions signals a high probability of near-term price depreciation.
  • Entering new long positions in these three equities is highly risky at present, given the strong negative momentum in analyst estimates and the bearish fundamental outlook implied by the report.
  • A potential reversal in these stocks would likely be preceded by a stabilization or positive inflection in their earnings estimate revisions; therefore, investors should monitor this specific data point before considering any bullish exposure.